The largest database of trusted experimental protocols

Liaison analyzer 310360

Manufactured by DiaSorin
Sourced in Italy

The LIAISON analyzer (310360) is a fully automated, random-access immunoassay analyzer designed for in vitro diagnostic testing. It performs chemiluminescent immunoassay tests to quantitatively determine the concentration of various analytes in biological samples.

Automatically generated - may contain errors

2 protocols using liaison analyzer 310360

1

Plasma SIRT1 and Fetuin-A Levels in Participants

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the beginning and end of the study, ten ccs of venous blood samples were taken, and after the separation of serum, SIRT and Fetuin levels were measured in the plasma of the participants. Blood samples were collected into tubes with and without EDTA. Blood samples without EDTA Centrifuged (Beckman Avanti J-25, USA) at a rate of 3000 rpm for 10 min in order to the separation of serum. Blood samples were kept at − 70 °C (Snijdes, Germany) in Diabetes Research Center and then transferred to the laboratory of Velayat Hospital of Qazvin University of Medical Sciences, and the measurements were carried out. Fasting plasma glucose (FPG) concentration was measured by the enzymatic method using an Abbot ModelAclyon 300, USA auto analyzer with Pars-Azmone kit (Tehran, Iran). Plasma insulin was measured by using a chemiluminescent immunoassay method (LIAISON analyzer (310360) Diasorin S.P.A., Verecelli, Italy). Insulin resistance (HOMA-IR) was calculated according to the following formula: HOMA-IR = (fasting insulin (U/ml) × FPG (mg/dl)/405) [17 (link)]. Serum levels of SIRT1 and Fetuin-A in participants’ plasma were measured using a special kit and by ELISA method (Diameter, Italy and Bioassay Technology Laboratory, China).
+ Open protocol
+ Expand
2

Glycemic Status and Inflammatory Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the beginning and end of the study, 10 cc of venous blood samples were taken and after separation of serum, biochemical parameters of glycemic status including fasting blood glucose (FBG), 2-hour Post Prandial (2hpp), (2-hour after breakfast), and HbA1c%, insulin and CRP measured in the plasma of the participants. Tubes with and without EDTA were used to collect blood samples. Tubes without EDTA were centrifuged (Beckman Avanti J-25, USA, 3000 rpm,10 min) and finally maintained at minus − 70 ° C for final measurements. FBG concentration was measured by the enzymatic method using an Abbot ModelAclyon 300, USA auto analyzer with Pars-Azmone kit (Tehran, Iran). The percentage of HbA1c was determined by high performance liquid chromatography (HPLC). Plasma insulin was measured by using a chemiluminescent immunoassay method (LIAISON analyzer (310,360) Diasorin S.P.A., Verecelli, Italy). Insulin resistance (IR) was calculated according to the following formula: Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (µU/ml) = (Fasting insulin (U/ml) × FBG (mg/dl)/405) [18 (link)]. CRP concentration was measured by using an immune turbid metric assay (Pars Azmoon kit. Iran).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!